Celonic Group, University College London in partnership to produce protein therapeutics using CHOvolution platform
Celonic Group, a Swiss-German contract development and manufacturing organization, and University College London (UCL), UK, have set up a partnership to enable UCL to use Celonic’s CHOvolution cell expression platform for the production of therapeutic protein candidates.